Elevation of serum KL-6 levels during treatment with tumor necrosis factor-α inhibitor in patients with psoriasis

被引：9
作者：
Mabuchi, Tomotaka [1 ]
Yamaoka, Hanako [1 ]
Kawai, Mayu [1 ]
Ota, Tami [1 ]
Ozawa, Akira [1 ]
机构：
[1] Tokai Univ, Dept Dermatol, Sch Med, Isehara, Kanagawa 2591193, Japan
来源：
JOURNAL OF DERMATOLOGY | 2014年 / 41卷 / 12期
关键词：
AD HOC COMMITTEE; RHEUMATOID-ARTHRITIS; BIOLOGICAL DMARDS; JAPAN COLLEGE; SAFETY;
D O I：
10.1111/1346-8138.12681
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1136 / 1137
页数：2
相关论文
共 50 条
  • [21] Association of gender, tumor necrosis factor inhibitor therapy, and myocardial infarction risk in patients with psoriasis
    Wu, Jashin J.
    Poon, Kwun-Yee T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (04) : 650 - 651
  • [22] Association Between Tumor Necrosis Factor Inhibitor Therapy and Myocardial Infarction Risk in Patients With Psoriasis
    Wu, Jashin J.
    Poon, Kwun-Yee T.
    Channual, Jennifer C.
    Shen, Albert Yuh-Jer
    ARCHIVES OF DERMATOLOGY, 2012, 148 (11) : 1244 - 1250
  • [23] Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-α inhibitors versus methotrexate
    Wu, Jashin J.
    Guerin, Annie
    Sundaram, Murali
    Dea, Katherine
    Cloutier, Martin
    Mulani, Parvez
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (01) : 81 - 90
  • [24] Elevation of Serum Tumor Necrosis Factor α in Patients with Periprosthetic Osteolysis: A Case-Control Study
    Chaganti, R. Krishna
    Purdue, Edward
    Sculco, Thomas P.
    Mandl, Lisa A.
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2014, 472 (02) : 584 - 589
  • [25] The effect of tumor necrosis factor inhibitor therapy on the incidence of myocardial infarction in patients with psoriasis: a retrospective study
    Shaaban, Dalia
    Al-Mutairi, Nawaf
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (01) : 3 - 7
  • [26] Healthcare-Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis: a Retrospective Study
    Dalen, Johan
    Luttropp, Karin
    Svedbom, Axel
    Black, Christopher M.
    Kachroo, Sumesh
    ADVANCES IN THERAPY, 2020, 37 (09) : 3746 - 3760
  • [27] Current tumor necrosis factor-α inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis
    Liang, GC
    Cordero, M
    Dyer, A
    Chang, RW
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (09) : 1662 - 1665
  • [28] Factors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-α Treatment
    Borekci, Sermin
    Atahan, Ersan
    Yilmaz, Deniz Demir
    Mazican, Nejdiye
    Duman, Berna
    Ozguler, Yesim
    Musellim, Benan
    Hamuryudan, Vedat
    Ongen, Gul
    RESPIRATION, 2015, 90 (03) : 191 - 198
  • [29] Association Between the Type and Length of Tumor Necrosis Factor Inhibitor Therapy and Myocardial Infarction Risk in Patients With Psoriasis
    Wu, Jashin J.
    Poon, Kwun-Yee T.
    Bebchuk, Judith D.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (08) : 899 - 903
  • [30] Effects of adjuvant pidotimod therapy on levels of inflammatory factors and expressions of serum GM-CSF and KL-6 in elderly patients with mycoplasma pneumonia
    Xu, Lin
    Zhao, Ying
    Wu, Shaokui
    Song, Qingying
    Ouyang, Zhanghong
    Zhang, Xiangyan
    Zhang, Cheng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (10): : 11899 - 11907
12345